-
Product Insights
Leukodystrophies – Drugs In Development, 2023
Global Markets Direct’s, ‘Leukodystrophies - Drugs In Development, 2023’, provides an overview of the Leukodystrophies pipeline landscape. The report provides comprehensive information on the therapeutics under development for Leukodystrophies, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Inherited Neurodegenerative Diseases – Drugs In Development, 2023
Global Markets Direct’s, ‘Inherited Neurodegenerative Diseases - Drugs In Development, 2023’, provides an overview of the Inherited Neurodegenerative Diseases pipeline landscape. The report provides comprehensive information on the therapeutics under development for Inherited Neurodegenerative Diseases, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Primary Progressive Multiple Sclerosis (PPMS) – Drugs In Development, 2023
Global Markets Direct’s, ‘Primary Progressive Multiple Sclerosis (PPMS) - Drugs In Development, 2023’, provides an overview of the Primary Progressive Multiple Sclerosis (PPMS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primary Progressive Multiple Sclerosis (PPMS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Prader-Willi Syndrome (PWS) – Drugs In Development, 2023
Global Markets Direct’s, ‘Prader-Willi Syndrome (PWS) - Drugs In Development, 2023’, provides an overview of the Prader-Willi Syndrome (PWS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Prader-Willi Syndrome (PWS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Sector Analysis
United States (US) Power Market Trends and Analysis by Capacity, Generation, Transmission, Distribution, Regulations, Key Players and Forecast to 2035
United States (US) Power Market Report Overview The cumulative installed capacity in the United States (US) power market was 1310.5 GW in 2022. In 2022, thermal power dominated the capacity segment, followed by renewable and nuclear power. The installed capacity in the US power market is expected to grow at a CAGR of more than 3% during 2022-2035, owing to the rapid growth in the country’s renewable power. US Power Market Outlook, 2022-2035 (GW) Buy the Full Report for More...
-
Sector Analysis
United States (US) Nuclear Power Market Analysis by Size, Installed Capacity, Power Generation, Regulations, Key Players and Forecast to 2035
United States (US) Nuclear Power Market Report Overview The cumulative capacity for nuclear power in the US was 94.7 GW in 2022. The market is anticipated to decline at a negative CAGR of less than 1% from 2023 to 2035. The US nuclear power market research report highlights installed capacity and power generation trends from 2010 to 2035. The report discusses the key insights about the major active and upcoming nuclear power plants in the US. US Nuclear Power Market...
-
Product Insights
Ophthalmic Diagnostic Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ophthalmic Diagnostic Equipment Pipeline Market Report Overview Ophthalmic diagnostic equipment helps in examining the eye for study purposes as well as for the treatment of different pathologies of the eye. The Ophthalmic Diagnostic Equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the...
-
Product Insights
Point of Care (POC) Analyzers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Point of Care (POC) Analyzers Pipeline Market Report Overview POC analyzers are small handheld or bench-top analyzers often used in small laboratories and physician labs with less workload and daily sample inflow. They often use disposable test cartridges and can provide faster results. The Point of Care (POC) analyzers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein...
-
Product Insights
Acquired Gene or Chromosome Alterations Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
Acquired Gene or Chromosome Alterations Pipeline Market Report Overview Acquired Gene or Chromosome Alterations are reagents employed for genetic testing to detect cancer-causing or related alterations. The Acquired Gene or Chromosome Alterations pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...